Methyl 4-amino-5-(ethylsulfonyl)-2-methoxybenzoate

We are Methyl 4-amino-5-(ethylsulfonyl)-2-methoxybenzoate CAS:80036-89-1 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:Methyl 4-amino-5-(ethylsulfonyl)-2-methoxybenzoate
CAS.NO: 80036-89-1
Synonyms:
Benzoic acid, 4-amino-5-(ethylsulfonyl)-2-methoxy-, methyl ester

Molecular Formula:C11H15NO5S
Molecular Weight:273.30600

Physical and Chemical Properties:
Density: 1.289g/cm3
Boiling point: 514.5ºC at 760 mmHg
Melting point: /
Flash point: 265ºC
Refractive index: 1.534

Specification:
Appearance: White  powder
Purity:≥99%
Moisture:NMT 0.5%
Heavy Metals:NMT 0.002%
Single impurities:NMT 0.1%
Total impurities:NMT 1%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Amisulpride CAS:71675-85-9

Methyl 4-amino-5-(ethylsulfonyl)-2-methoxybenzoate


Related News: Zhejiang Huahai Pharmaceutical: It is a leading company in domestic APIs, especially in the field of cardiovascular drugs.5'-Deoxy-5-fluorocytidine Zhejiang Huahai Pharmaceutical: It is a leading company in domestic APIs, especially in the field of cardiovascular drugs.2-phenoxyethyl 4-aminobenzoate CAS:88938-23-2 Zhejiang Huahai Pharmaceutical: It is a leading company in domestic APIs, especially in the field of cardiovascular drugs.2,4,6-trihidroxibenzaldehído CAS:487-70-7 In the context of increasingly tight global productive capacity cooperation in the pharmaceutical industry, some multinational pharmaceutical companies have chosen to abandon their original full industrial chain model and shift their focus to market operations. R & D, clinical, and production links reduce costs through outsourcing. Patented APIs came into being.In the context of increasingly tight global productive capacity cooperation in the pharmaceutical industry, some multinational pharmaceutical companies have chosen to abandon their original full industrial chain model and shift their focus to market operations. R & D, clinical, and production links reduce costs through outsourcing. Patented APIs came into being.

Related Products
Product Name
1,2,4-triazole-1-carboximidamide,hydrochloride View Details
5-Bromo-2-fluorotoluene View Details
methyl (2S)-2-benzyl-3-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]propanoate,hydrochloride View Details
Ethyl 1-(trifluoroMethyl)cyclopropanecarboxylate manufacturer 4-Bromo-2,3-difluorophenol manufacturer 2-Methoxybenzonitrile manufacturer 3-Mercapto-2-pentanone manufacturer 5-Fluoro-2-iodotoluene manufacturer